Fulcrum Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.588; its P/E ratio is -4.56; Fulcrum Therapeutics is scheduled to report earnings on May 14, 2024, and the estimated EPS forecast is $-0.44. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 871.00K	$ 759.00K	$ 880.00K	-	$ 685.00K
Gross Profit	$ 871.00K	$ 759.00K	$ 880.00K	-	-
EBIT	$ -24.76M	$ -24.02M	$ -23.78M	$ -24.78M	$ -27.97M
EBITDA	$ -24.76M	$ -25.07M	$ -23.18M	$ -25.58M	$ -27.98M
Net Income Common Stockholders	$ -24.76M	$ -24.02M	$ -23.78M	$ -24.78M	$ -26.14M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 236.22M	$ 257.09M	$ 278.16M	$ 297.84M	$ 202.92M
Total Assets	$ 257.69M	$ 278.88M	$ 300.33M	$ 321.12M	$ 226.69M
Total Debt	$ 10.82M	$ 11.49M	$ 12.16M	$ 12.80M	$ 13.42M
Net Debt	$ -225.40M	$ -245.60M	$ -266.00M	$ -285.04M	$ -189.50M
Total Liabilities	$ 22.50M	$ 23.42M	$ 24.90M	$ 24.86M	$ 27.74M
Stockholders Equity	$ 235.19M	$ 255.46M	$ 275.43M	$ 296.26M	$ 198.94M
Cash Flow	-
Free Cash Flow	$ -23.23M	$ -22.97M	$ 3.96M	$ -24.12M	-
Operating Cash Flow	$ -23.16M	$ -22.91M	$ 3.96M	$ -24.12M	-
Investing Cash Flow	$ 18.35M	$ 19.02M	-	$ -93.94M	-
Financing Cash Flow	$ 287.00K	-	-	$ 117.69M	-

Currency in USD

Fulcrum Therapeutics Earnings and Revenue History

Income Statement >

Fulcrum Therapeutics Debt to Assets

Balance Sheet >

Fulcrum Therapeutics Cash Flow

Cash Flow >

Fulcrum Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing